Prostacyclin pathway vasodilators in patients with chronic thromboembolic pulmonary hypertension (CTEPH): A systemic review and meta‐analysis of randomized controlled trials

Abstract Although surgical and interventional therapy has emerged as the primary treatment for patients with chronic thromboembolic pulmonary hypertension (CTEPH), there remains a subset of patients who need medication therapy. This study aimed to evaluate the efficacy and safety outcomes of prostac...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Weijun Li, Xingxue Pang, Jun Chen, Xiaoxia Ren, Huaibing Zhao, Xu Wang, Ning Zhao, Dayi Hu, Zhongyi Jin
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2024-10-01
coleção:	Pulmonary Circulation
Assuntos:	chronic thromboembolic pulmonary hypertension prostacyclin pulmonary hypertension
Acesso em linha:	https://doi.org/10.1002/pul2.70001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!